Provenge (sipuleucel-T) is created by exposing the immune cells of someone with prostate cancer to a protein that “teaches” ...

Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the ...

According to a Boston University study head and neck cancer (HNC) trials have been less diverse between 2000 and 2023.

Learn more about lung cancer clinical trials at MSK. This study was partly supported by the National Institutes of ...

When breast cancer patients are done with treatment, they may wonder about the disease coming back. In many cases, doctors ...

The overall survival observed across the three groups was 19 months, representing, “to our knowledge, the longest overall ...

Boston is a city recognized worldwide for its cutting-edge advancements in science and medicine, especially in the field of ...

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

The myeloMATCH blood cancer trial is part of a larger effort by the NIH to find more personalized cancer treatments.

Manchester scientists and clinicians have been awarded a major cash boost to fund radiotherapy research which uses artificial ...

The University of Birmingham’s Cancer Research UK Clinical Trials Unit is leading a new trial to improve outcomes for ...

In Louisiana and across the country, pancreatic cancer continues to be one of the most aggressive and deadly forms of the ...